Cardiovascular Disease Risk: Improving Prediction Using Imaging Biomarkers

| | Health Imaging | Cardiac Imaging

Tuesday, Nov. 27, 4:30-6:00 p.m. | S404AB

A trio of speakers discuss the roles of and guidelines for the predictive use of cardiac imaging modalities—carotid ultrasound, cardiac CT and cardiac MRI.

Speaker Information:

  • Joseph F. Polak, MD, MPH, Tufts Medical Center, Boston
  • J. Jeffrey Carr, MD, Wake Forest Baptist Medical Center, Winston-Salem, N.C.
  • David A. Bluemke, MD, MPH, Johns Hopkins University School of Medicine, Baltimore

 

Related Content

Global shortage of nuclear imaging isotopes may be over
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT
FDA clears AI tool that flags signs of heart disease in chest CT scans
AI-enabled plaque assessments help cardiologists ID high-risk CAD patients
Abbott CGM sensors can now be worn during common imaging procedures
New data highlight long-term benefits of HeartFlow’s AI-based CAD evaluations

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup